Avricore Health Inc experienced a remarkable surge in its stock price, gaining 50% in a single trading session.
Avricore Health Inc (AVCR.V) saw its stock price climb significantly yesterday, closing at CA$0.09 after an impressive 50% increase. This surge can be attributed to positive developments surrounding the company's innovative HealthTab™ platform and strategic partnerships.
Advertisement
Avricore Health Inc
AVCR.V
AVCR.V
Avricore Health Inc
WealthAwesomeMarket cap
$11.37M
52W high
$0.10
52W low
$0.04
1W change
+38.46%
Beta
0.32
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
185.6%
Annualized
90-Day Vol
137.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.10 | C$0.05 – C$0.18 |
| 60 trading days | C$0.10 | C$0.04 – C$0.25 |
| 90 trading days | C$0.11 | C$0.04 – C$0.33 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider Avricore's recent performance as a signal of growing market confidence in its business model and future prospects.
50% Surge in Stock Price
Avricore Health Inc's stock price increased from CA$0.06 to CA$0.09 in yesterday's trading session, reflecting strong investor interest.
Bull case
The recent collaboration with Abbott to distribute point-of-care testing products through HealthTab™ positions Avricore as a leader in pharmacy-based healthcare solutions. This partnership could lead to significant revenue growth as more pharmacies adopt their innovative testing methods.
Bear case
Despite yesterday's gains, investors should remain cautious. Avricore's stock still faces volatility, and its long-term success depends on how well it executes its growth strategies and gains acceptance in the market.
Advertisement
Key Developments Fueling Growth
Avricore's recent announcement about granting stock options and its collaboration with Abbott has generated excitement among investors. The partnership aims to enhance the HealthTab™ platform, designed to improve patient care through rapid testing in community pharmacies. This innovative approach is expected to significantly expand Avricore's market presence.
Market Response and Future Outlook
The market's positive response to Avricore's developments indicates strong investor confidence. However, potential investors should keep an eye on the company's ability to effectively execute its growth strategies. As Avricore continues to innovate and expand, its stock performance will closely tie to its operational success and market conditions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
